Auro Laboratories Limited has scheduled its 37th Annual General Meeting (AGM) for Tuesday, August 11, 2026, at 11:30 a.m. IST. The meeting will be conducted through video conferencing (VC) or other audio-visual means (OAVM) in compliance with the Companies Act, 2013, and SEBI Listing Regulations. The company has dispensed with the requirement to send physical copies of the Annual Report for FY 2025-2026 to members, opting instead for electronic distribution to those with registered email addresses.

The Notice of the 37th AGM and the Integrated Annual Report for FY 2025-2026 will be sent electronically to members whose email addresses are registered with the company, its Registrar & Transfer Agents (RTA), or Depository Participant. Physical copies of the report will be dispatched only to members who specifically request them by emailing cs@aurolabs.com with their Folio Number or DPID and Client ID. These documents will also be available on the company's website and the BSE Limited website.

Auro Laboratories Limited has provided an e-voting facility through CDSL, allowing members to cast votes remotely before and during the AGM. Members can attend and participate in the meeting exclusively through the VC/OAVM facility. Detailed instructions regarding remote e-voting and virtual meeting attendance will be included in the official notice convening the meeting. Members attending via VC/OAVM will be counted for the purpose of quorum under Section 103 of the Companies Act, 2013.

The company has advised members holding shares in physical form to register their email addresses with the company or RTA to receive electronic communications. Those holding shares in demat form must update their email IDs and mobile numbers with their respective Depository Participants to facilitate e-voting and participation in virtual meetings.

Key Meeting Details

Auro Laboratories Limited has approved the re-appointment of Mr. Kiran Suresh Kulkarni as Whole Time Director for a term of three years, effective from May 24, 2027, to May 23, 2030. The decision, taken at a board meeting on June 30, 2026, is based on the recommendations of the Nomination and Remuneration Committee and is subject to the approval of shareholders at the ensuing Annual General Meeting. The re-appointment ensures continuity in leadership as the current term of Mr. Kulkarni expires on May 23, 2027.

The Board of Directors met on June 30, 2026, to transact business including the re-appointment. Mr. Kulkarni is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other such authority. The company has disclosed the necessary details in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

37th Annual General Meeting

The Notice convening the 37th Annual General Meeting of the Company has been scheduled for Tuesday, August 11, 2026. The meeting will be held through Video-Conferencing ("VC") and Other Audio-Visual Means ("OAVM"). Shareholders will vote on the resolution to re-appoint Mr. Kulkarni during this meeting.

Director Profile

Mr. Kiran Suresh Kulkarni brings over 25 years of experience in the QC/QA department of API manufacturing companies. He currently oversees the quality control and general management functions at the manufacturing facility of the Company.